A recent randomized clinical trial has found that men with localized, intermediate-risk prostate cancer recovered faster and ...
The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
When I introduced the Ivermectin/Mebendazole-based RESET-5™ Protocol on April 5th, 2026, I was unaware that a landmark ...
From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...
(HealthDay News) — For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing hormone-releasing hormone (LHRH) agonists as androgen deprivation ...
As a board-certified urologist who specializes in male sexual dysfunction and men’s health, I often find that people can be pretty dismissive of treatment for erectile dysfuncti ...
Background: Survivors of cancer in adolescence and young adulthood are at increased risk for subsequent primary neoplasms, but studies using Canadian data are limited. We sought to quantify the risk ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results